These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1756335)
41. [Volumetric brain changes and quantitative EEG in normal aging and Alzheimer's dementia]. Förstl H; Besthorn C; Sattel H; Zerfass R; Geiger-Kabisch C; Schreiter-Gasser U; Hentschel F Nervenarzt; 1996 Jan; 67(1):53-61. PubMed ID: 8676989 [TBL] [Abstract][Full Text] [Related]
42. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799 [TBL] [Abstract][Full Text] [Related]
43. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study. Foundas AL; Leonard CM; Mahoney SM; Agee OF; Heilman KM Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):81-9. PubMed ID: 9150507 [TBL] [Abstract][Full Text] [Related]
44. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063 [TBL] [Abstract][Full Text] [Related]
45. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia. LeMay M; Stafford JL; Sandor T; Albert M; Haykal H; Zamani A J Comput Assist Tomogr; 1986; 10(5):802-9. PubMed ID: 3489017 [TBL] [Abstract][Full Text] [Related]
46. Cerebral atrophy in motor neuron disease evaluated by computed tomography. Poloni M; Mascherpa C; Faggi L; Rognone F; Gozzoli L J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1102-5. PubMed ID: 7161605 [TBL] [Abstract][Full Text] [Related]
47. [Homonymous hemianopia and posterior cortical atrophy]. Formaglio M; Krolak-Salmon P; Tilikete C; Bernard M; Croisile B; Vighetto A Rev Neurol (Paris); 2009 Mar; 165(3):256-62. PubMed ID: 19124140 [TBL] [Abstract][Full Text] [Related]
48. [The significance of cerebral white matter changes in CT images in Alzheimer's disease]. Barcikowska M; Gołebiowski M; Pfeffer A Neurol Neurochir Pol; 1997; 31(2):237-45. PubMed ID: 9380254 [TBL] [Abstract][Full Text] [Related]
49. Age-related differences in computed tomographic scan measurements. Stafford JL; Albert MS; Naeser MA; Sandor T; Garvey AJ Arch Neurol; 1988 Apr; 45(4):409-15. PubMed ID: 3355396 [TBL] [Abstract][Full Text] [Related]
50. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. Capizzano AA; Ación L; Bekinschtein T; Furman M; Gomila H; Martínez A; Mizrahi R; Starkstein SE J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):822-7. PubMed ID: 15145992 [TBL] [Abstract][Full Text] [Related]
51. Malignant progression in parietal-dominant atrophy subtype of Alzheimer's disease occurs independent of onset age. Na HK; Kang DR; Kim S; Seo SW; Heilman KM; Noh Y; Na DL Neurobiol Aging; 2016 Nov; 47():149-156. PubMed ID: 27592283 [TBL] [Abstract][Full Text] [Related]
52. Organic factors and the clinical features of late paranoid psychosis: a comparison with Alzheimer's disease and normal ageing. Förstl H; Dalgalarrondo P; Riecher-Rössler A; Lotz M; Geiger-Kabisch C; Hentschel F Acta Psychiatr Scand; 1994 May; 89(5):335-40. PubMed ID: 8067272 [TBL] [Abstract][Full Text] [Related]
53. [The clinico-tomographic correlates in Alzheimer's disease]. Selezneva ND; Kolykhanov IV; Nikiforuk NM; Savvateva NIu; Ermilova EN; Vavilov SB; Gavrilova SI Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):65-9. PubMed ID: 8009938 [TBL] [Abstract][Full Text] [Related]
54. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Luxenberg JS; Haxby JV; Creasey H; Sundaram M; Rapoport SI Neurology; 1987 Jul; 37(7):1135-40. PubMed ID: 3496557 [TBL] [Abstract][Full Text] [Related]
56. Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type. De Leon MJ; Ferris SH; George AE; Reisberg B; Kricheff II; Gershon S Neurobiol Aging; 1980; 1(1):69-79. PubMed ID: 7266737 [TBL] [Abstract][Full Text] [Related]
57. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease. Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182 [TBL] [Abstract][Full Text] [Related]
58. Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. Biessels GJ; De Leeuw FE; Lindeboom J; Barkhof F; Scheltens P J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):304-7. PubMed ID: 16484636 [TBL] [Abstract][Full Text] [Related]
59. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
60. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Bradley KM; Bydder GM; Budge MM; Hajnal JV; White SJ; Ripley BD; Smith AD Br J Radiol; 2002 Jun; 75(894):506-13. PubMed ID: 12124237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]